TY - JOUR
T1 - How to make pancreatic β cells - Prospects for cell therapy in diabetes
AU - Nir, Tomer
AU - Dor, Yuval
N1 - Funding Information:
YD is supported by a career development award from JDRF.
PY - 2005/10
Y1 - 2005/10
N2 - One promising approach for the cure of diabetes is the replacement of lost insulin-expressing β cells by cell or regenerative therapy. The recent development of an effective islet transplantation procedure has focused attention on the limiting supply of β cells. Various sources for new β cells are therefore being considered, including embryonic stem cells, adult stem cells and transdifferentiation of certain types of differentiated cells, so far with limited success. The major physiological mechanism for adult β cell formation was recently shown to be β cell proliferation. This finding underscores the potential use of terminally differentiated β cells as a starting material for enhancement of β cell mass.
AB - One promising approach for the cure of diabetes is the replacement of lost insulin-expressing β cells by cell or regenerative therapy. The recent development of an effective islet transplantation procedure has focused attention on the limiting supply of β cells. Various sources for new β cells are therefore being considered, including embryonic stem cells, adult stem cells and transdifferentiation of certain types of differentiated cells, so far with limited success. The major physiological mechanism for adult β cell formation was recently shown to be β cell proliferation. This finding underscores the potential use of terminally differentiated β cells as a starting material for enhancement of β cell mass.
UR - http://www.scopus.com/inward/record.url?scp=25844465752&partnerID=8YFLogxK
U2 - 10.1016/j.copbio.2005.07.005
DO - 10.1016/j.copbio.2005.07.005
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 16084716
AN - SCOPUS:25844465752
SN - 0958-1669
VL - 16
SP - 524
EP - 529
JO - Current Opinion in Biotechnology
JF - Current Opinion in Biotechnology
IS - 5
ER -